ProShares UltraShort Nasdaq Biotechnology
Price through Sep 30 · Flows through Sep 30. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET +$445 OVER THIS RANGE
Flows are quiet — the past month netted out near zero, while the price has returned -38.6% so far this year. At 0.95% a year it is not the cheapest way in — GSIG has a reported fee of 0.14%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
| 1 week | +3.4% |
| 1 month | +4.7% |
| 3 months | -14.5% |
| 6 months | -40.0% |
| YTD | -38.6% |
| 1 year | -53.1% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | +$460 |
| 1 year | +$2K |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat BIS on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.4B | +$187M | -93bp on fee · +$187M in over the month | Head-to-head |
| STIP iShares 0-5 Year TIPS Bond ETF | 0.03% | $16.3B | +$489M | -92bp on fee · +$489M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $56.2B | +$717M | -91bp on fee · +$717M in over the month | Head-to-head |
| SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.03% | $14.1B | +$235M | -92bp on fee · +$235M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $122.8B | +$2.3B | -90bp on fee · +$2.3B in over the month | Head-to-head |